Brexit risks disrupting the supply of medical radioisotopes, says Committee

X-Ray of a chest
11 December 2017

The EU Home Affairs Sub-Committee has written to the Rt Hon Greg Clark MP, Secretary of State for Business, Energy and Industrial Strategy, and the Rt Hon Jeremy Hunt MP, Secretary of State for Health, seeking clarification on a number of issues related to the health implications of the UK leaving Euratom after the UK leaves the EU.


On the 22 November 2017, the Committee held a one-off evidence session on the health implications of leaving Euratom with medical practitioners. The Committee found that leaving Euratom risks disrupting the time-sensitive supply chain of medical radioisotopes, putting patients health and wellbeing at risk.

Chairman's Quote

"The Committee is very concerned that the health implications of leaving Euratom have not been given the priority that they require within Government. The UK imports 80% of radioisotopes from the EU and time is running out to set up a system to replace the current structure that relies on the safe and timely transport and delivery of these items.

"The best chance of securing a reliable and timely supply of medical radioisotopes between the UK and the EU, and for maintaining our world-leading position in nuclear medicine research, would be, as our witnesses said, to have as close a relationship as possible with Euratom post-Brexit.

"We invite ministers to tell us what is being done at Government level to coordinate the work that needs to happen to ensure that the import of radioisotopes from the EU does not take longer, cost more or carry a higher risk of encountering delays.”

Further Information 

Image: iStockphoto

More news on: Parliament, government and politics, Parliament, European Union, Health services and medicine, Medicine, House of Lords news, Lords news, Committee news, Exiting the European Union

Share this page